{"id":38812,"date":"2020-08-28T07:33:49","date_gmt":"2020-08-28T07:33:49","guid":{"rendered":"https:\/\/i-base.info\/htb\/?p=38812"},"modified":"2020-08-28T09:14:23","modified_gmt":"2020-08-28T09:14:23","slug":"ema-extends-indication-for-darunavir-r-to-include-adolescents-12-years","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/38812","title":{"rendered":"EMA extends indication for darunavir\/r to include adolescents >12 years"},"content":{"rendered":"<p><b>EMA monthly review<\/b><\/p>\n<p><strong>On 23 July 2020, the\u00a0Committee for Medicinal Products for Human Use\u00a0(CHMP) recommended extending the indication for daruavir\/r to adolescents age 12 and older who weigh &gt;40 kg.<\/strong><\/p>\n<p>For full details please see the updated summary of product characteristics.<\/p>\n<p>Darunavir\/r is marketed by Janssen-Cilag with the trade name Prezista.<\/p>\n<p>Reference<\/p>\n<p>EMA. Prezista.<br \/>\n<a href=\"https:\/\/www.ema.europa.eu\/en\/medicines\/human\/summaries-opinion\/prezista\">https:\/\/www.ema.europa.eu\/en\/medicines\/human\/summaries-opinion\/prezista<\/a><\/p>\n<p><em>This article was originally posted on 25 August 2020.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>EMA monthly review On 23 July 2020, the\u00a0Committee for Medicinal Products for Human Use\u00a0(CHMP) recommended extending the indication for daruavir\/r to adolescents age 12 and older who weigh &gt;40 kg. For full details please see the updated summary of product &hellip;<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[],"class_list":["post-38812","post","type-post","status-publish","format-standard","hentry","category-antiretrovirals"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/38812","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=38812"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/38812\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=38812"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=38812"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=38812"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}